Influencia de distintos escenarios sobre los factores de mal pronóstico en pacientes con COVID-19
DOI:
https://doi.org/10.23938/ASSN.1033Palabras clave:
COVID-19, Factores de riesgo, Variantes víricasDescargas
Citas
Núñez Orantos MJ, Candel FJ, González del Castillo J. Adaptación de los factores de mal pronóstico en pacientes con COVID-19 al escenario actual. An Sist Sanit Navar 2023; 46(1): e1029. https://doi.org/10.23938/ASSN.1029
Blanco-Taboada AL, Fernández-Ojeda MR, Castillo-Matus MM, Galán-Azcona MD, Salinas-Gutiérrez J, Ruiz-Romero MV. Factores de mal pronóstico en pacientes hospitalizados por COVID-19. An Sist Sanit Navar 2022; 45(2): e1000. https://doi.org/10.23938/ASSN.1000
Ibarra-Estrada MÁ, García-Salas Y, Mireles-Cabodevila E, López-Pulgarín JA, Chávez-Peña Q, García-Salcido R et al. Use of airway pressure release ventilation in patients with acute respiratory failure due to COVID-19: results of a single-center randomized controlled trial. Crit Care Med 2022; 50(4): 586-594. https://doi.org/10.1097/CCM.0000000000005312
Berenguer J, Ryan P, Rodríguez-Baño J, Carcas A, Jarrín I, Yllescas M et al. Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain. Clin Microbiol Infect 2020; 26: 1525-1536. https://doi.org/10.1016/j.cmi.2020.07.024
Pan F, Yang L, Li Y, Liang B, Li L, Ye T et al. Factors associated with death outcome in patients with severe coronavirus disease-19 (COVID-19): a case-control study. Int J Med Sci 2020; 17: 1281-1292. https://doi.org/10.7150/ijms.46614
Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med 2020; 180: 934. https://doi.org/10.1001/jamainternmed.2020.0994
Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 2020; 8: 475-481. https://doi.org/10.1016/S2213-2600(20)30079-5
Clift AK, Coupland CAC, Keogh RH, Diaz-Ordaz K, Williamson E, Harrison EM et al. Algoritmo de predicción de riesgo vivo (QCOVID) para el riesgo de ingreso hospitalario y mortalidad por coronavirus 19 en adultos: estudio de cohorte de validación y derivación nacional. BMJ 2020; 371: m3731. https://doi.org/10.1136/bmj.m3731
Maslo C, Friedland R, Toubkin M, Laubscher A, Akaloo T, Kama B. Characteristics and outcomes of hospitalized patients in South Africa during the COVID-19 omicron wave compared with previous waves. JAMA 2022; 327(6): 583-584. https://doi.org/10.1001/jama.2021.24868
Rotondo JC, Martini F, Maritati M, Mazziotta C, Di Mauro G, Lanzillotti C et al. SARS-CoV-2 infection: new molecular, phylogenetic, and pathogenetic insights. Efficacy of current vaccines and the potential risk of variants. Viruses 2021; 13(9): 1687. https://doi.org/10.3390/v13091687
Wall EC, Wu M, Harvey R, Kelly G, Warchal S, Sawyer C et al. Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination. The Lancet 2021; 397: 2331-2333. https://doi.org/10.1016/S0140-6736(21)01290-3
Hoes J, Boef AGC, Knol MJ, de Melker HE, Mollema L, van der Klis FRM et al. Socioeconomic status is associated with antibody levels against vaccine preventable diseases in the Netherlands. Front Public Health 2018; 6: 209. https://doi.org/10.3389/fpubh.2018.00209
Zimmermann P, Curtis N. Factors that influence the immune response to vaccination. Clin Microbiol Rev 2019; 32(2):e00084-18. https://doi.org/10.1128/CMR.00084-18
Kennedy NA, Lin S, Goodhand JR, Chanchlani N, Hamilton B, Bewshea C et al; Contributors to the CLARITY IBD study. Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines in patients with IBD. Gut 2021; 70(10): 1884-1893. https://doi.org/10.1136/gutjnl-2021-324789
Hippisley-Cox J, Coupland CA, Mehta N, Keogh RH, Diaz-Ordaz K, Khunti K et al. Risk prediction of COVID-19 related death and hospital admission in adults after COVID-19 vaccination: national prospective cohort study. BMJ 2021; 374: n2244. https://doi.org/10.1136/bmj.n2244
Tegally H, Wilkinson E, Giovanetti M, Iranzadeh A, Fonseca V, Giandhari J et al. Detection of a SARS-CoV-2 variant of concern in South Africa. Nature 2021; 592: 438-443. https://doi.org/10.1038/s41586-021-03402-9
Gallo Marin B, Aghagoli G, Lavine K, Yang L, Siff EJ, Chiang SS et al. Predictors of COVID-19 severity: a literature review. Rev Med Virol 2021; 31: e2146. https://doi.org/10.1002/rmv.2146
Wynants L, Van Calster B, Collins GS, Riley RD, Heinze G, Schuit E et al. Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal. BMJ 2020; 369: m1328. https://doi.org/10.1136/bmj.m1328
Publicado
Cómo citar
Número
Sección
Licencia
Esta obra está bajo una licencia internacional Creative Commons Atribución-CompartirIgual 4.0.
La revista Anales del Sistema Sanitario de Navarra es publicada por el Departamento de Salud del Gobierno de Navarra (España), quien conserva los derechos patrimoniales (copyright ) sobre el artículo publicado y favorece y permite la difusión del mismo bajo licencia Creative Commons Reconocimiento-CompartirIgual 4.0 Internacional (CC BY-SA 4.0). Esta licencia permite copiar, usar, difundir, transmitir y exponer públicamente el artículo, siempre que siempre que se cite la autoría y la publicación inicial en Anales del Sistema Sanitario de Navarra, y se distinga la existencia de esta licencia de uso.
